Long GV, Atkinson V, Lo S, et al. Randomized phase 2 study of nivolumab (nivo) or nivo+ipilimumab (ipi) in patients (pts) with melanoma brain metastases (mets): Anti-PD1 Brain Collaboration (ABC). SMR 2017, abstract SMR09-4.
Sotorasib plus panitumumab bij refractair colorectaal carcinoom met KRAS G12C-mutatie
dec 2023 | Maag-darm-leveroncologie